MSB 6.21% 94.0¢ mesoblast limited

Chronic Lower Back Pain - the sleeping giant., page-155

  1. 5,717 Posts.
    lightbulb Created with Sketch. 2058
    "Future trial to include roughly same patient population as previous phase III -"

    Roughly same number of patients, but FDA has agreed we can limit to patients who have had CLBP for less than 68 months. That is where we saw the best results.. (Before fibrosis sets in, according to SI)

    That 68 months was the median for patients in our first phase 3 trial. However, the doctors deemed that to be "forever," and in practice would expect to use our treatment much, much earlier. Definitely before considering surgery, and some insurance plans will entertain surgery as soon as 6 months after other less invasive treatments fail.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
0.055(6.21%)
Mkt cap ! $1.061B
Open High Low Value Volume
88.5¢ 95.0¢ 88.0¢ $2.057M 2.251M

Buyers (Bids)

No. Vol. Price($)
8 31934 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.0¢ 34180 9
View Market Depth
Last trade - 11.06am 06/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.